Table 3.
Use of Adjunctive Therapies for PARDS over Time for the Entire Cohort
| Adjunctive Therapy | Anytime (n = 624) | Day 0 (n = 621) | Day 1 (n = 613) | Day 2 (n = 583) | Day 3 (n = 560) | P Value |
|---|---|---|---|---|---|---|
| cNMB | 196 (31.4) | 121 (19.5) | 139 (22.7) | 120 (20.6) | 110 (19.6) | 0.494 |
| Corticosteroids for PARDS | 64 (10.3) | 38 (6.1) | 45 (7.3) | 45 (7.7) | 39 (7.0) | 0.727 |
| iNO | 81 (13.0) | 42 (6.8) | 56 (9.1) | 56 (9.6) | 48 (8.6) | 0.351 |
| Prone positioning | 63 (10.1) | 37 (6.0) | 40 (6.5) | 36 (6.2) | 27 (4.8) | 0.639 |
| HFOV | 58 (9.3) | 13 (2.1) | 41 (6.7) | 43 (7.4) | 43 (7.7) | <0.0001 |
| ECMO | 19 (3.0) | 6 (1.0) | 13 (2.1) | 14 (2.4) | 17 (3.0) | 0.224 |
Definition of abbreviations: cNMB = continuous neuromuscular blockade; ECMO = extracorporeal membrane oxygenation; HFOV = high-frequency oscillatory ventilation; iNO = inhaled nitric oxide; PARDS = pediatric acute respiratory distress syndrome.
Results are presented as n (%).